Mr. Prashant Nagre - Chief Executive Officer
Prashant Nagre is the Chief Executive Officer at Fermenta Biotech Limited. With over 20 years in the pharmaceuticals industry, he has in-depth experience across spheres encompassing the API business, production, Research and Development. Additionally, Prashant has acquired practical experience in regulatory compliance.
At FBL, Prashant leads strategy and oversees day to day operations including Business Development and budgeting. He also focuses on further building and developing the various strengths of FBL i.e. manufacturing, R&D and allied activities. He forms a core member of the product development team and is also responsible for creating and nurturing large business account relationships.
Known for his meticulous planning skills, Prashant adds impetus to timely deliveries of products, quality orientation and human resource development within the company.
He is a Master in Management Sciences, and also holds a Post Graduate Diploma in International Trade (IIFT, New Delhi) besides a Degree in Pharmacy.
Mr. Suresh Uniyal - Vice President : Manufacturing
Mr. Suresh Uniyal, has been with Fermenta Biotech for more than 20 years and plays a key role in developing and motivates a team of functional manufacturing leaders, ensuring attainment of plant targets and objectives and champion the development of a lean manufacturing culture.
A Science graduate from Garhwal University. Mr. Uniyal started his career as chemist at Indian Drugs and Pharmacuetical Ltd and in October 1990, joined Fermenta Biotech Ltd as Assistant Production Manager. He became integral part of FBL’s pioneering efforts in commercializing Penicillin G Acylase catalyst in India.
Before he was promoted to Vice President, he held various responsibilities in the organization and today, Mr. Uniyal draws combined experience of over 30 years in field of enzyme, enzyme application, manufacturing operations in API & Biotech to name the few. His experienced inputs and insights into facility creation, management, regulatory compliances combined with project management skills were instrumental in the growth of the organization.
Mr Uniyal’s trouble shooting insights and team management skills, he has always inspired the young team to take responsibilities and perform. Apart from his managerial and technical skills, he brings to the table his ability to liaison and nurture public relationships which has helped the organization to undertake corporate social responsibilities as well. He is member of many social forums in Kullu, including membership in Advisory Committee (Biotechnology) reconstituted by the Registrar, H.P. University, Shimla (HP).
His strong contribution to the development and execution of the company's manufacturing strategic plan has helped manage budgets and drive cost efficiencies within the manufacturing operation.
Mr. Prashant Gudhate - Vice President- Corporate Quality Assurance & Regulatory Affairs.
Prashant holds post graduate degree in Organic Chemistry from Pune University. Prior to joining us, he was associated with Dr. Reddy's Laboratories as Director – CQA, responsible for overall quality function for all API plants of DRL located in India.
With over more than 25 years in the pharmaceutical industry, he has acquired expertise in multiple functions - Quality Assurance, Regulatory Affairs, Quality Control, Manufacturing & Basic Research.
During his tenure, he has handled various positions with increasing level of responsibilities with well known Pharma companies like, Sandoz, Aarti Industries, RPG Life Sciences and Hoechst Marion Roussel Ltd. (Aventis). He has excellent exposure for auditing practices followed by regulatory authorities- USFDA, EDQM, TGA, WHO & ISO 9001. Besides post graduate degree, he is also certified by TUV as lead auditor for Quality Management Systems of ISO 9001:2008
At FBL, Prashant is responsible for providing leadership across the organisation, to elevate Quality systems, in order to assure Quality is built- in to Product’s meeting current regulatory as well as customer expectations.
His overall experience contributes to formulate regulatory strategies to meet requirements of various regulatory authorities. He oversees and participates in the preparation and filing of regulatory documents with FDA and international regulatory agencies, maintaining successful collaboration with regulatory agency representatives.